English
ENTEROLOGICS, INC.
EDGAR19 filing records in this dataset, filed from 2010-02-17 to 2013-11-26. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 18 thousand USD Source
Exact value
17975 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 38 million shares Source
Exact value
38013391 shares
Reported share-count change
2.29% · 850 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2013-11-26.
Financial data available through: 2012-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 2 of 11 periods available· newest 2010-12-31
- Net income: 4 of 11 periods available· newest 2012-12-31
- Operating cash flow: 3 of 11 periods available· newest 2012-12-31
- capital expenditure: No compatible figures in this window
- Total assets: 4 of 11 periods available· newest 2012-12-31
- Total liabilities: 4 of 11 periods available· newest 2012-12-31
- Current assets: 3 of 11 periods available· newest 2011-12-31
- Current liabilities: 4 of 11 periods available· newest 2012-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 2011-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2012-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 709,940Prior period
−USD 223,013
–
Current period
−USD 932,953
–
Exact inputs and evidence
-932953 − -223013 = -709940 USD
-223013 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source-932953 USD · 2012-01-01 – 2012-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 6,037Prior period
−USD 193,938
–
Current period
−USD 199,975
–
Exact inputs and evidence
-199975 − -193938 = -6037 USD
-193938 USD · 2011-01-01 – 2011-12-31
Inspect prior input Prior source-199975 USD · 2012-01-01 – 2012-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue, Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2009 2009-01-01 – 2009-12-31 | −USD 8,099 Exact valueExact value: -8099 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2010 2010-01-01 – 2010-12-31 | −USD 72,611 Exact valueExact value: -72611 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 50,156 Exact valueExact value: -50156 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2011 2011-01-01 – 2011-12-31 | −USD 223,013 Exact valueExact value: -223013 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 193,938 Exact valueExact value: -193938 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2012 2012-01-01 – 2012-12-31 | −USD 932,953 Exact valueExact value: -932953 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 199,975 Exact valueExact value: -199975 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
19 filings · 551 latest values · 551 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001483731, 1483731, edgar:1483731
Also known as ENTEROLOGICS, INC., Enterologics, Inc.